Utilization Analysis of Antidiabetic Essential Medicines in the Outpatient of Our Hospital from 2012 to 2014

VernacularTitle:我院2012－2014年门诊降糖药类基本药物使用情况分析
Author: Yin LIAO ; Limin SHI
Publication Type:Journal Article
Keywords: Antidiabetic drugs; DDDs; Consumption sum; DDC; Essential medicine
From: China Pharmacy 2015;(21):2927-2930
CountryChina
Language:Chinese
Abstract: OBJECTIVE:To provide reference for clinical rational use of antidiabetic essential medicines. METHODS:Retro-spective analysis was used to sort and analyze the consumption sum,DDDs and DDC of antidiabetic drugs in the outpatient of our hospital from May 1st,2012 to Apr. 30th,2014. RESULTS:The consumption sum and DDDs of insulin and oral antidiabetic drugs had upward trend. The top 3 consumption sum and DDDs of oral antidiabetic drugs were acarbose,metformin and glimepiri-de,and the highest DDDs of insulin was short-acting and premixed recombinant human insulin,all of them were in the National Essential Medicine List (2012 edition);DDDs of Glibenclamide tablets,Glipizide tablets and Chinese patent medicine were rela-tively small;DDC in long-acting insulin analogues was obviously higher than other kinds of insulin. The sales ratio of essential medicines was increased from 10.48% to 67.78% after National Essential Medicine List (2012 edition)carried out. CONCLU-SIONS:The use of antidiabetic drugs in the outpatient of our hospital is basically rational. Acarbose and metformin have the high-est DDDs,and DDDs of insulin analogues grow rapidly.